Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
IPOPEMA Securities's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was -104.01%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for IPOPEMA Securities's 3-Year ROIIC % or its related term are showing as below:
WAR:IPE's 3-Year ROIIC % is ranked worse than 92.41% of 659
companies
in the Capital Markets industry
Industry Median: 2.6
vs WAR:IPE: -104.01
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
IPOPEMA Securities 3-Year ROIIC % Related Terms
IPOPEMA Securities 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for IPOPEMA Securities's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:IPE vs MS, GS, SCHW: 3-Year ROIIC % Comparison
For the Capital Markets subindustry, IPOPEMA Securities's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IPOPEMA Securities 3-Year ROIIC % vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, IPOPEMA Securities's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where IPOPEMA Securities's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
IPOPEMA Securities (WAR:IPE) has a 3-Year ROIIC % of -104.01 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on IPOPEMA Securities and its competitors. According to the industry distribution chart, IPOPEMA Securities ranks #609 out of 659 companies in the Capital Markets industry, placing it in the top 92.4%.
Is IPOPEMA Securities' 3-Year ROIIC % too high?
IPOPEMA Securities' current 3-Year ROIIC % is -104.01. Based on the distribution chart, IPOPEMA Securities ranks #609 out of 659 companies in the Capital Markets industry, which is in the bottom quartile relative to peers. Overall, IPOPEMA Securities has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IPOPEMA Securities' 3-Year ROIIC % compare to MS and GS?
According to the Capital Markets industry distribution chart, IPOPEMA Securities ranks #609 out of 659 companies for 3-Year ROIIC %. This places IPOPEMA Securities in the lower half of its industry. The industry median 3-Year ROIIC % is 2.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Capital Markets company?
The median 3-Year ROIIC % among Capital Markets companies is 2.60, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on IPOPEMA Securities and its competitors. For the Capital Markets industry, the median 3-Year ROIIC % is 2.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IPOPEMA Securities's current 3-Year ROIIC % is -104.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IPOPEMA Securities stock overvalued right now?
Based on GuruFocus' analysis, IPOPEMA Securities (WAR:IPE) is currently considered Significantly Overvalued. The stock's GF Value™ is zł3.62, compared to a current price of zł7.30 — trading 101.7% above its estimated fair value. The current 3-Year ROIIC % is -104.01. IPOPEMA Securities' overall GF Score™ is 57/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For IPOPEMA Securities (WAR:IPE), the current 3-Year ROIIC % is -104.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IPOPEMA Securities (WAR:IPE) Overvalued in 2026?
Based on GuruFocus' analysis, IPOPEMA Securities stock appears to be overvalued.
The current stock price of zł7.30 is trading 101.7% above its estimated GF Value™ of zł3.62.
GuruFocus considers IPOPEMA Securities to be Significantly Overvalued.
Key valuation signals for WAR:IPE:
3-Year ROIIC %: -104.01
GF Value™: zł3.62 vs. price of zł7.30 (101.7% above fair value)
No single metric tells the full story. See the WAR:IPE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IPOPEMA Securities SA is focused on brokerage activities, Business and management consulting, running an investment fund company and creating and managing investment funds, Management of portfolios of brokerage financial instruments, IT management activities, and IT consulting activities. It specializes in brokerage and company analysis services, investment banking services, as well as the distribution of investment products and investment advisory services addressed to a wide range of individual investors, the creation and management of closed-end and open-end investment funds and asset management, as well as business and IT consulting services.
57GF Score
Get the complete analysis for WAR:IPE
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:IPE has been successfully added to your 
